Announcement of Availability of the Report on Carcinogens, Thirteenth Edition, 60169 [2014-23748]
Download as PDF
mstockstill on DSK4VPTVN1PROD with NOTICES
Federal Register / Vol. 79, No. 193 / Monday, October 6, 2014 / Notices
hundred thousand dollars ($1,300,000)
to the Commission to be used for
equitable relief, including restitution,
and any attendant expenses for the
administration of such equitable relief.
To facilitate the payment of redress, Part
VI of the proposed order requires
Wacoal America to provide to the
Commission a searchable electronic file
containing the name and contact
information of all consumers who
purchased the iPants garments directly
from respondent from January 1, 2011,
through the date of entry of the order.
Part VIII of the proposed order requires
respondent to comply with the
provisions of Appendix A to the order,
which sets out the methods for notifying
consumers who may be entitled to file
a claim for consumer redress.
Part IX of the proposed order is
triggered whenever the human clinical
testing requirement in either Part II or
Part III applies. Part IX of the proposed
order requires the company to secure
and preserve all underlying or
supporting data and documents
generally accepted by experts in the
field as relevant to an assessment of the
test. There is an exception for a
‘‘Reliably Reported’’ test defined as a
test published in a peer-reviewed
journal that was not conducted,
controlled, or sponsored by any
proposed respondent or supplier. Also,
the published report must provide
sufficient information about the test for
experts in the relevant field to assess the
reliability of the results.
Part X of the proposed order contains
recordkeeping requirements for
advertisements and substantiation
relevant to any representation covered
by the proposed order. Parts XI, XII and
XIII of the proposed order require
respondent to provide copies of the
order to its personnel; to notify the
Commission of changes in corporate
structure that might affect compliance
obligations under the order; and to file
compliance reports with the
Commission. Part XIV provides that the
order will terminate after twenty (20)
years, with certain exceptions.
The purpose of this analysis is to
facilitate public comment on the
proposed order, and it is not intended
to constitute an official interpretation of
the complaint or and proposed order or
to modify the proposed order’s terms in
any way.
By direction of the Commission.
Donald S. Clark,
Secretary.
[FR Doc. 2014–23681 Filed 10–3–14; 8:45 am]
BILLING CODE 6750–01–P
VerDate Sep<11>2014
17:17 Oct 03, 2014
Jkt 235001
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Announcement of Availability of the
Report on Carcinogens, Thirteenth
Edition
National Toxicology Program
(NTP), National Institute of
Environmental Health Sciences
(NIEHS); National Institutes of Health
(NIH).
ACTION: Availability of the Report on
Carcinogens, Thirteenth Edition (13th
RoC).
AGENCY:
The Department of Health and
Human Services released the 13th RoC
to the public on October 2, 2014. The
report is available on the RoC Web site
at: https://ntp.niehs.nih.gov/go/roc13 or
electronically from the Office of the RoC
(see ADDRESSES below).
DATES: The 13th RoC is available to the
public on October 2, 2014.
ADDRESSES: Dr. Ruth Lunn, Director,
Office of the RoC, NTP, NIEHS, P.O. Box
12233, MD K2–14, Research Triangle
Park, NC 27709; telephone: (919) 316–
4637; FAX: (301) 480–2970;
lunn@niehs.nih.gov.
SUMMARY:
FOR FURTHER INFORMATION CONTACT:
Questions or comments concerning the
13th RoC should be directed to Dr. Ruth
Lunn (telephone: (919) 316–4637 or
lunn@niehs.nih.gov).
SUPPLEMENTARY INFORMATION:
Background Information on the RoC
The RoC is a congressionally
mandated document that identifies and
discusses agents, substances, mixtures,
or exposure circumstances (collectively
referred to as ‘‘substances’’) that may
pose a hazard to human health by virtue
of their carcinogenicity. Substances are
listed in the report as either known or
reasonably anticipated to be human
carcinogens. The listing of a substance
in the RoC indicates a potential hazard,
but does not establish the exposure
conditions that pose a cancer hazard to
individuals in their daily lives. For each
listed substance, the RoC provides
information from cancer studies that
support the listing as well as
information about potential sources of
exposure and current federal regulations
to limit exposures. Each edition of the
RoC is cumulative, that is, it lists newly
reviewed substances in addition to
substances listed in the previous
edition. Information about the RoC is
available on the RoC Web site (https://
ntp.niehs.nih.gov/go/roc13) or by
contacting Dr. Lunn (see ADDRESSES
above).
PO 00000
Frm 00044
Fmt 4703
Sfmt 4703
60169
The NTP prepares the RoC on behalf
of the Secretary of Health and Human
Services. For the 13th RoC, the NTP
followed an established, multi-step
process with multiple opportunities for
public input, and used established
criteria to evaluate the scientific
evidence on each candidate substance
under review (https://ntp.niehs.nih.gov/
go/rocprocess).
New Listings to the 13th RoC
The 13th RoC contains 243 listings,
some of which consist of a class of
structurally related chemicals or agents.
There are three new listings and one
revised listing in this edition. The
revised listing is for ortho-toluidine,
which was previously listed as
reasonably anticipated to be a human
carcinogen and is now listed as known
to be a human carcinogen. The new
listings in the 13th RoC are three
substances—1-bromopropane, cumene,
and pentachlorophenol and by-products
of its synthesis—each listed as
reasonably anticipated to be a human
carcinogen.
Dated: September 26, 2014.
Linda S. Birnbaum,
Director, National Institute of Environmental
Health Sciences, and National Toxicology
Program.
[FR Doc. 2014–23748 Filed 10–3–14; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Administration for Children and
Families
Submission for OMB Review;
Comment Request
Title: Temporary Assistance for Needy
Families/National Directory of New
Hires Match Results Report
OMB No.: 0970–0311
Description: Section 453(j)(3) of the
Social Security Act (the Act) allows for
matching between the National
Directory of New Hires (maintained by
the Federal Office of Child Support
Enforcement (OCSE) and State TANF
Agencies for purposes of carrying out
responsibilities under programs funded
under part A of Title IV of the Act. To
assist OCSE and the Office of Family
Assistance (OFA) in measuring savings
to the TANF program attributable to the
use of NDNH data matches, the State
TANF Agencies have agreed to provide
OCSE with a written description of the
performance outputs and outcomes
attributable to the State TANF Agency’s
use of NDNH match results. This
information will help OCSE
E:\FR\FM\06OCN1.SGM
06OCN1
Agencies
[Federal Register Volume 79, Number 193 (Monday, October 6, 2014)]
[Notices]
[Page 60169]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2014-23748]
=======================================================================
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Announcement of Availability of the Report on Carcinogens,
Thirteenth Edition
AGENCY: National Toxicology Program (NTP), National Institute of
Environmental Health Sciences (NIEHS); National Institutes of Health
(NIH).
ACTION: Availability of the Report on Carcinogens, Thirteenth Edition
(13th RoC).
-----------------------------------------------------------------------
SUMMARY: The Department of Health and Human Services released the 13th
RoC to the public on October 2, 2014. The report is available on the
RoC Web site at: https://ntp.niehs.nih.gov/go/roc13 or electronically
from the Office of the RoC (see ADDRESSES below).
DATES: The 13th RoC is available to the public on October 2, 2014.
ADDRESSES: Dr. Ruth Lunn, Director, Office of the RoC, NTP, NIEHS, P.O.
Box 12233, MD K2-14, Research Triangle Park, NC 27709; telephone: (919)
316-4637; FAX: (301) 480-2970; lunn@niehs.nih.gov.
FOR FURTHER INFORMATION CONTACT: Questions or comments concerning the
13th RoC should be directed to Dr. Ruth Lunn (telephone: (919) 316-4637
or lunn@niehs.nih.gov).
SUPPLEMENTARY INFORMATION:
Background Information on the RoC
The RoC is a congressionally mandated document that identifies and
discusses agents, substances, mixtures, or exposure circumstances
(collectively referred to as ``substances'') that may pose a hazard to
human health by virtue of their carcinogenicity. Substances are listed
in the report as either known or reasonably anticipated to be human
carcinogens. The listing of a substance in the RoC indicates a
potential hazard, but does not establish the exposure conditions that
pose a cancer hazard to individuals in their daily lives. For each
listed substance, the RoC provides information from cancer studies that
support the listing as well as information about potential sources of
exposure and current federal regulations to limit exposures. Each
edition of the RoC is cumulative, that is, it lists newly reviewed
substances in addition to substances listed in the previous edition.
Information about the RoC is available on the RoC Web site (https://ntp.niehs.nih.gov/go/roc13) or by contacting Dr. Lunn (see ADDRESSES
above).
The NTP prepares the RoC on behalf of the Secretary of Health and
Human Services. For the 13th RoC, the NTP followed an established,
multi-step process with multiple opportunities for public input, and
used established criteria to evaluate the scientific evidence on each
candidate substance under review (https://ntp.niehs.nih.gov/go/rocprocess).
New Listings to the 13th RoC
The 13th RoC contains 243 listings, some of which consist of a
class of structurally related chemicals or agents. There are three new
listings and one revised listing in this edition. The revised listing
is for ortho-toluidine, which was previously listed as reasonably
anticipated to be a human carcinogen and is now listed as known to be a
human carcinogen. The new listings in the 13th RoC are three
substances--1-bromopropane, cumene, and pentachlorophenol and by-
products of its synthesis--each listed as reasonably anticipated to be
a human carcinogen.
Dated: September 26, 2014.
Linda S. Birnbaum,
Director, National Institute of Environmental Health Sciences, and
National Toxicology Program.
[FR Doc. 2014-23748 Filed 10-3-14; 8:45 am]
BILLING CODE 4140-01-P